SNDX - Syndax Pharmaceuticals, Inc.

Name: Syndax Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Classified under Biotechnology (Health Care sector), SNDX's insider flows are most useful compared with peers in the same group.

Compare Health Care sector insider flows →

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Metzger Michael A	484.8K	$3.09M	-
Dir	Podlesak Dennis	239.8K	-	-
CFO	Goldan Keith A.	139.3K	$2.64M	-
Dir	Katkin Keith	124.0K	-	-
Dir	Jarrett Jennifer	114.0K	-	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 8, 2026	Metzger Michael A52	Chief Executive Officer	Sale+OE10b5-1	32,375	$24.24	$784,776.48	-6.3%	-30.1%	-
Jun 12, 2026	Botwood Nicholas A.J.	Head of R&D, CMO	Sale+OE10b5-1	65,515	$18.07	$1,183,642.90	-51.8%	+3.1%	-
Jun 1, 2026	Goldan Keith A.49	Chief Financial Officer	Sell	1,177	$18.99	$22,351.23	-0.8%	+2.3%	-
Jun 1, 2026	Metzger Michael A52	Chief Executive Officer	Sell	6,847	$18.99	$130,024.53	-1.4%	+2.3%	-
Feb 9, 2026	Metzger Michael A52	Chief Executive Officer	Sell	17,159	$21.03	$360,819.45	-3.4%	+0.9%	-
Feb 9, 2026	Goldan Keith A.49	Chief Financial Officer	Sell	3,410	$21.03	$71,705.48	-2.4%	+0.9%	-
Feb 6, 2026	Metzger Michael A52	Chief Executive Officer	Sell	7,412	$20.62	$152,835.44	-1.4%	-2.2%	-
Feb 6, 2026	Goldan Keith A.49	Chief Financial Officer	Sell	2,082	$20.62	$42,930.84	-1.4%	-2.2%	-
Sep 8, 2025	Metzger Michael A52	Chief Executive Officer	Sale+OE10b5-1	157,307	$16.41	$2,582,021.37	-34.5%	+22.4%	+22.1%
Aug 18, 2025	Podlesak Dennis62	Director	Sale+OE10b5-1	57,600	$15.19	$875,099.52	-23.1%	+8.3%	+25.5%

Understand these filings

How to Read SEC Form 4 Filings →Understanding Insider Buying Signals →What is Insider Trading? A Complete Guide →Cluster Buying: When Multiple Insiders Buy Together →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC